title: A double-blind comparative study of ketanserin with atenolol in essential hypertension.
abstract: Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily for 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.
authors.affiliation: Centre for Cardiovascular Disease and Arterial Hypertension, Institute INRCA, Ancona, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Antonicelli
authors.forename: A
authors.initials: A
authors.lastname: Andreoni
authors.forename: G
authors.initials: G
authors.lastname: Saccomanno
authors.forename: C
authors.initials: C
authors.lastname: Gambini
authors.forename: E
authors.initials: E
authors.lastname: Paciaroni
mesh_terms: D000328:Adult; D000368:Aged; D001262:Atenolol / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007650:Ketanserin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic
chemical_list: D001262:Atenolol; D007650:Ketanserin